Project ADMEC

Basic data

Title:
ADMEC
Duration:
01/10/2014 to 31/03/2018
Abstract / short description:
Prospective randomized trial of an adjuvant therapy of completely resected Merkel Cell Carcinoma (MCC) with 3mg/kg BW Ipilimumab (Yervoy®) every 3 weeks for 12 weeks versus observation
Keywords:
Merkelzellkarzinom (Merkel Cell Carcinoma)

Involved staff

Managers

Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine

Contact persons

Faculty of Medicine
University of Tübingen
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine

Funders

Essen, Nordrhein-Westfalen, Germany
Help

will be deleted permanently. This cannot be undone.